Companies / United Arab Emirates
MoH Approves Exubera
January 2007 | Industry NewsDoctors in the UAE have welcomed the decision by the Ministry of Health (MoH) to approve US drugmaker Pfizer's revolutionary inhaled insulin treatment Exubera.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.
